SMOX and neoplasm: Future studies on FlgE immunostimulation should extend the current work from epithelial cells to immune cells (i.e., dendritic cells and macrophages), from the current soluble antigen immunization models to cellular antigenic models (i.e., tumor cells), and from the current PAO1 FlgE to FlgE molecules of other bacteria.